DOCSLIB.ORG

ANNUAL REPORT 2014 Contents

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
ANNUAL REPORT 2014 Contents ANNUAL REPORT 2014 Contents Introduction ..................................................................3 Mission Who we are, what we do Garvan’s aspirations Reports ..........................................................................4 Chairman’s report ...........................................................4 Executive Director’s report ............................................5 Garvan Research Foundation Chairman’s report ...........6 The Organisation .........................................................7 Garvan at a Glance ......................................................8 The year at a glance .......................................................8 Philanthropic income ......................................................8 Staff and student profile ................................................9 Scientific publications ....................................................9 Public and community engagement ..............................9 Research Divisions and Centre .................................10 Bone Biology .................................................................10 Cancer ..........................................................................14 Diabetes and Metabolism ............................................18 Immunology .................................................................22 Neuroscience ...............................................................26 Kinghorn Centre for Clinical Genomics ........................30 Governance .................................................................35 Garvan Institute of Medical Research ..........................35 Garvan Research Foundation .......................................39 Leaders in Science Seminars ....................................42 Garvan Community ...................................................44 Life Governors ..............................................................44 Partners for the Future .................................................44 Volunteers .....................................................................44 2014 supporters ...........................................................45 Young Garvan supporters .............................................47 Love Your Sister ...........................................................47 Bequests ......................................................................47 Peer Reviewed Funding ............................................48 Financial Highlights ...................................................50 Income statement ........................................................50 Balance sheet ...............................................................51 2 Mission The mission of the Garvan Institute of Medical Research is to make significant contributions to medical research that will change the directions of science and medicine and have major impacts on human health. Who we are, what we do Garvan pioneers studies into For more than 50 years, significant • Osteoporosis some of the most widespread breakthroughs have been achieved • Immunological diseases such diseases affecting our by Garvan scientists in the as asthma, rheumatoid arthritis community. Research at Garvan understanding and treatment of and multiple sclerosis. is focused upon understanding diseases such as: the role of molecular and cellular Garvan’s ultimate goal is • Cancer processes in health and disease prevention, treatment or cure of as the basis for developing • Diabetes and obesity these major diseases. future preventions, treatments • Neurological diseases such and cures. Garvan is leading the as Alzheimer’s disease, nation in using genomic analysis Parkinson’s disease, hearing to accelerate discovery and loss, mental illnesses and enable precision medicine. eating disorders Garvan’s aspirations • To become the most advanced osteoporosis, diabetes, obesity, • To embrace and uphold institute in the region in the and immunological, skeletal a culture of collegiality, adoption, application and and neurological diseases, and collaboration, inclusivity, integration of next generation influence health policy. consideration, safety, genomic and computational transparency and high • To attract, develop and approaches and technologies ethical standards. support exceptionally talented in investigative and researchers with leading • To engage stakeholders and translational research. edge programs addressing the community with our • To advance knowledge in our key conceptual and practical achievements and research key areas of focus that will questions in human biology, vision so that we attract the lead to better understanding, and the translation of new significant government and donor reduced incidence and knowledge and technologies support needed to empower our improved treatments for cancer, into clinical applications. transformative agenda. GARVAN 3 Chairman’s Report Garvan Institute of Medical Research Before I accepted the invitation to become the Chair of the Board of the Garvan Institute of Medical Research, disease avoidance and mitigation, leading to I naturally undertook due diligence far better health for individuals and society, about the Institute and its people. with many benefits to our economy and I was impressed. quality of life. However, my due diligence was inadequate. Recognising the importance for NSW and I had underestimated the quality of Garvan’s Australia, this potential has attracted $24m in staff. What I also discovered is that Garvan NSW Government support for leading-edge leads the nation and is among the leaders of programs that can take advantage of KCCG’s the world in the development and application infrastructure. These include sequencing of genomic technologies in medical research populations that have survived to old age and clinical translation. The pace of change without any of the common problems, is exhilarating. Just over a decade ago it including cognitive decline, and identifying cost more than a billion dollars to sequence wellness factors, as well as identifying the human genome. This year the US inherited cancer risk. A number of projects company that leads the field, Illumina, chose are also underway with clinicians around the Garvan to be one of the first centres in the state to investigate the genetic contributions world to acquire the technology capable of to schizophrenia, melanoma, mitochondrial sequencing human genomes for a base cost disease and congenital heart disease, among of US$1,000. many others to come. This choice reflected respect for the I encourage all readers to go to Garvan’s Australian healthcare system and medical website to learn more about KCCG and to research capability, and for the leadership at explore the range of outstanding research Garvan which understands that genomics and researchers that we are fortunate to is not only essential to understanding have at Garvan. human disease, but also that it is ready for the clinic. To this end, with the generous I would also like to thank a number of support of The Kinghorn Foundation, Garvan Board members, who retired or resigned was able to purchase the Illumina HiSeq in 2014, namely Jonathan Anderson, John XTen sequencing system which is capable Horvath AO, Warren Scott, Greg Paramor of sequencing more than 300 genomes AO and Lisa McIntyre, for their outstanding every week. Garvan also established the contributions to Garvan over many years. Kinghorn Centre for Clinical Genomics I would also like to welcome our new (KCCG), with the analytical pipelines required Board Members Helen Nugent AO, Patricia to assemble and interpret the avalanche of O’Rourke and Anthony Schembri. new information. Dr John Schubert AO KCCG now has more than 30 staff and is developing wonderful collaborations with clinicians and scientists around the country This choice reflected respect for the and beyond to explore the genetic basis of Australian healthcare system and “ illness. This includes inherited and acquired medical research capability, and for the genetic disabilities, cancer diagnosis and leadership at Garvan which understands “that genomics is not only essential to adverse drug reactions among others. Personal genome sequencing will become understanding human disease, but also the norm in the not-too-distant future and that it is ready for the clinic. incorporated into healthcare, focused on 4 We continue to strengthen our relationships with UNSW Australia and with our partners Executive on the Darlinghurst precinct, including St Vincent’s Hospital and the Victor Chang Cardiac Research Institute, working strategically to build critical mass and Director’s capability in medical research and translation into clinical practice, as well as training opportunities for students. In January 2014 we also launched a revamped website (www.garvan.org.au), Report which has enhanced content. The website offers virtual tours of our facilities and links to a number of social media platforms that we are increasingly using to communicate 2014 was a year of growth and renewal. our activities and achievements. I came to Garvan three years ago with the intention of transforming Our researchers had another successful the Institute into the first of the next- year in obtaining peer-reviewed grant and generation medical research institutes fellowship support, with Garvan once again that places understanding human among the best performing institutions genomic information at the centre of its in the nation. However many challenges research and translational endeavours. remain
Load more

Recommended publications
  • Patterns, Paradoxes and Personalities Medical History Museum, University of Melbourne the Story of Cancer Is Complex and Extremely Personal
    THE cancer puzzle patterns, paradoxes and personalities Medical History Museum, University of Melbourne The story of cancer is complex and extremely personal. One in two Australian men and one in three Australian women will be diagnosed with cancer by the age of 85. For generations, doctors and researchers have been searching for remedies for this disease, which has long been shrouded in fear and dread. While surgery, radiotherapy and chemotherapy are still the main treatments, radically new approaches and technologies are emerging, together with a much more sophisticated understanding of the causes and very nature of cancer. Central to the story of cancer in Victoria has been the contribution of the University of Melbourne, in undertaking fundamental and applied research, developing treatments, training clinicians and scientists, educating the public, and advocating for change. Significant figures in the Melbourne Medical School, such as Professor Peter MacCallum, have helped build the infrastructure that underpins cancer services for the Victorian community. The cancer puzzle: Patterns, paradoxes and personalities explores the roles of individuals, public education campaigns and research efforts, as well as revealing patients’ insights through the work and writings of three contemporary artists who have cancer. the cancer puzzle PATTERNS, PARADOXES AND PERSONALITIES Edited by Jacqueline Healy Medical History Museum University of Melbourne Contents Foreword vii Published 2017 by the Medical History Museum, The exhibition The cancer puzzle: Patterns, paradoxes and personalities, Professor Mark Cook Faculty of Medicine, Dentistry and Health Sciences, curated by Dr Jacqueline Healy, was held at the Medical History University of Melbourne, Victoria, 3010, Australia Museum, University of Melbourne, from 1 August 2017 to Sponsor’s message ix 24 February 2018.
    [Show full text]
  • 2020 Frankfurt Book Fair Catalogue (PDF)
    Sharing new conversations and fresh ideas for living life well. October 2020 – July 2021 Contents AT THE TABLE 7 SUSTAINABLE LIVING 21 HOME AND FAMILY 27 PERSONAL TRANSFORMATION AND SELF HELP 37 BACKLIST 51 INDEX 75 SALES CONTACTS 78 Books for living life well. What a year it has been. Perhaps that is enough said on that! From a publishing perspective, it has reinforced our philosophy at Murdoch Books of publishing books that add value to people’s lives. What we call books for ‘living life well.’ A taste of our upcoming line-up includes food waste pioneer Ronni Kahn’s uplifting memoir, A Repurposed Life; Durkhanai Ayubi’s love letter to her family’s homeland, Parwana: Recipes and Stories from an Afghan Kitchen; Alice Zaslavsky’s joyous celebration of all things vegetable, In Praise of Veg; Bill Granger’s very grown up Australian Food; Duncan Welgemoed’s take-no- prisoners cookbook inspired by his South African Heritage and award-winning restaurant, Africola: Slow food, fast words, cult chef; bestselling international author Belinda Alexandra’s ode to the relationship between women and their cats, The Divine Feline; a first aid kit for anxiety in book form by Tammi Kirkness, The Panic Button Book; Emily Ehlers’ self help guide for the modern era, Hope is a Verb; and the mouth-watering and eye opening Amber & Rye: A Baltic food journey through Estonia, Latvia and Lithuania from Zuza Zak. Stay safe! Lou Johnson Publishing Director, Murdoch Books Lou Johnson is the Publishing Director of Murdoch Books. Kelly Doust’s career in publishing spans 20+ years in the roles She has previously held senior roles across leading publishing of publisher, publicity manager and as an author of eight books houses, including Managing Director for Simon and Schuster of fiction and non-fiction.
    [Show full text]
  • Therapeutic Options for Mucinous Ovarian Carcinoma
    Edinburgh Research Explorer Therapeutic options for mucinous ovarian carcinoma Citation for published version: Gorringe, KL, Cheasley, D, Wakefield, MJ, Ryland, GL, Allan, PE, Alsop, K, Amarasinghe, KC, Ananda, S, Bowtell, DDL, Christie, M, Chiew, Y, Churchman, M, Defazio, A, Fereday, S, Gilks, CB, Gourley, C, Hadley, AM, Hendley, J, Hunter, SM, Kaufmann, SH, Kennedy, CJ, Köbel, M, Le Page, C, Li, J, Lupat, R, Mcnally, OM, Mcalpine, JN, Pyman, J, Rowley, SM, Salazar, C, Saunders, H, Semple, T, Stephens, AN, Thio, N, Torres, MC, Traficante, N, Zethoven, M, Antill, YC, Campbell, IG & Scott, CL 2020, 'Therapeutic options for mucinous ovarian carcinoma', Gynecologic Oncology, vol. 156, no. 3, pp. 552-560. https://doi.org/10.1016/j.ygyno.2019.12.015 Digital Object Identifier (DOI): 10.1016/j.ygyno.2019.12.015 Link: Link to publication record in Edinburgh Research Explorer Document Version: Publisher's PDF, also known as Version of record Published In: Gynecologic Oncology Publisher Rights Statement: This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc- nd/4.0/).Contents lists available atScienceDirectGynecologic Oncologyjournal homepage:www.elsevier.com/locate/ygyno General rights Copyright for the publications made accessible via the Edinburgh Research Explorer is retained by the author(s) and / or other copyright owners and it is a condition of accessing these publications that users recognise and abide by the legal requirements associated with these rights. Take down policy The University of Edinburgh has made every reasonable effort to ensure that Edinburgh Research Explorer content complies with UK legislation.
    [Show full text]
  • Abstract Book Alfred Health Week Research Poster Display 23 – 27 October 2017
    Alfred Health Week Research Poster Display 23 – 27 October 2017 The Alfred Hospital ABSTRACT BOOK ALFRED HEALTH WEEK RESEARCH POSTER DISPLAY 23 – 27 OCTOBER 2017 RESEARCH DAY Tuesday, 24 October 2016, 12:00 PM – 1:00 PM AMREP Lecture Theatre 2017 KEYNOTE SPEAKER: The Hon. John Brumby AO Former Premier of Victoria, Chair, Foundation Committee, Global Health Alliance Melbourne; Faculty of Business and Economics, University of Melbourne “To the Bedside and Beyond: Medical Research and Victoria’s Future” 1 POSTER PRIZES Michael J Hall Memorial Prize for Respiratory Physiology Professor Daniel Czarny Prize for Allergy, Asthma and Clinical Immunology Research Lucy Battistel Prize for Allied Health Research Henrietta Law Memorial Prize for Allied Health Research Burnet Institute Prize for Infectious Diseases Research Monash Comprehensive Cancer Consortium Prize for Cancer Research Noel and Imelda Foster Prize for Cardiovascular Research Baker Heart and Diabetes Institute Prize for Cardiovascular Research Baker Heart and Diabetes Institute Prize for Diabetes Research Senior Medical Staff Prize for Basic Science/Laboratory-Based Research Senior Medical Staff Prizes for Clinical/Public Health Research Tony Charlton Prize for Cardiac Surgical Research Monash Alfred Psychiatry Research Centre Prize for Psychiatry Research The Greg Barclay Nursing Research Award The Senior Medical Staff Award 2 CONTENTS CATEGORY PAGE ALLERGY / ASTHMA / IMMUNITY 1. HOW DO THE PROXIMAL AND PERIPHERAL ASTHMATIC AIRWAYS RESPOND WHEN PROVOKED 15 DIRECTLY AND INDIRECTLY? Dharmakumara M, Stuart-Andrews C, Zubrinich C, Thompson B 2. ACINAR VENTILATION HETEROGENEITY IS INCREASED IN IDIOPATHIC PULMONARY FIBROSIS 15 (IPF) AND COMBINED PULMONARY FIBROSIS AND EMPHYSEMA (CPFE) Ellis M, Prasad J, Westall G, Thompson B 3.
    [Show full text]
  • Genomic Analysis of Low‐Grade Serous Ovarian Carcinoma To
    Journal of Pathology J Pathol 2020; 00: 000–000 ORIGINAL PAPER Published online 28 October 2020 in Wiley Online Library (wileyonlinelibrary.com) DOI: 10.1002/path.5545 Genomic analysis of low-grade serous ovarian carcinoma to identify key drivers and therapeutic vulnerabilities Dane Cheasley1,2 , Abhimanyu Nigam1,2, Magnus Zethoven1,3, Sally Hunter2, Dariush Etemadmoghadam2, Timothy Semple4, Prue Allan5, Mark S Carey6, Marta L Fernandez6, Amy Dawson6, Martin Köbel7, David G Huntsman8, Cécile Le Page9 , Anne-Marie Mes-Masson9, Diane Provencher9, Neville Hacker10, Yunkai Gao1,2, David Bowtell11, Anna deFazio12, Kylie L Gorringe2† and Ian G Campbell1,2†* 1 Cancer Genetics Laboratory, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia 2 Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, VIC, Australia 3 Bioinformatics Consulting Core, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia 4 Molecular Genomics Core, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia 5 Department of Clinical Pathology, Peter MacCallum Cancer Centre, and University of Melbourne, Melbourne, VIC, Australia 6 Department of Obstetrics & Gynaecology, Faculty of Medicine, University of British Columbia, Vancouver, BC, Canada 7 Department of Pathology and Laboratory Medicine, University of Calgary, Calgary, AB, Canada 8 Department of Pathology and Laboratory Medicine, Faculty of Medicine, University of British Columbia, Vancouver, BC, Canada 9 Centre de Recherche du Centre Hospitalier de l’Université de Montréal (CRCHUM) and
    [Show full text]
  • Perth Dining
    HOW THE WEST WAS WON It’s not just the resource sector that’s booming in Perth: a vibrant new drinking and dining culture is changing the way the west is fed and watered. WORDS MAX VEENHUYZEN PHOTOGRAPHY ROBErt FRITH Seafaring and seasonal at Rockpool Bar photography: earl carter & Grill, Perth SEPTEMBEr 2012 QANTAS 95 PERTH FINE DINING Cinnamon rose quail with wood-roasted pumpkin, beans and pomegranate at Pata Negra (left); Restaurant Amusé (below) arolynne and Hadleigh Troy don’t know what is crazier: the fact they held an all-dessert degustation at their lauded East Perth diner, Restaurant Amusé, or that the event sold out in days with a waiting list big enough to fill a week of encore performances. WhileC dishes such as bite-sized gin and tonic trifles, bee pollen milkshakes and smoky hay custard afforded guests immediate gratification, the night’s success carried with it inklings of some- thing even sweeter: the city’s attitude to food and drink as a whole. When the Troys opened Amusé back in 2007, dining out was virtually confined to Fridays and Saturdays. Hadleigh admits he The city itself is a flurry of activity with the skyline-changing reckoned on needing to keep only a skeleton kitchen team on City Square on St Georges Terrace something of a hub, at least during the week (five years on and Amusé is invariably booked for locals Scott and Angie Taylor. Just as the siblings’ cafe/ out every night, Tuesday to Saturday). These days, with locals gourmet/deli Beaufort Street Merchant (488 Beaufort Street, exposed to travel and the globe-shrinking power of the internet, Highgate, 08 9328 6299) helped put the inner-city neighbour- Perth has embraced a vibrant eating and drinking culture that’s hoods of Highgate and Mount Lawley on the food map, Scott is au fait with national and global trends.
    [Show full text]
  • Impact of an Allied Health Prehabilitation Service for Haematologic Patients Receiving High Dose Chemotherapy in a Large Cancer Centre
    Impact of an Allied Health Prehabilitation Service for Haematologic Patients Receiving High Dose Chemotherapy in A Large Cancer Centre Jessica Crowe ( [email protected] ) Peter MacCallum Cancer Centre https://orcid.org/0000-0002-7913-0013 Jill Francis The University of Melbourne Melbourne School of Health Sciences Lara Edbrooke Peter MacCallum Cancer Centre Jenelle Loeliger Peter MacCallum Cancer Centre Trish Joyce Peter MacCallum Cancer Centre Christina Prickett Peter MacCallum Cancer Centre Alicia Martin Peter MacCallum Cancer Centre Amit Khot Peter MacCallum Cancer Centre Linda Denehy Melbourne School of Health Sciences: The University of Melbourne Melbourne School of Health Sciences The Centre for Prehabilitation and Peri-operative Care Peter MacCallum Cancer Centre Research Article Keywords: prehabilitation, implementation, allied health, autologous stem cell transplant, high dose chemotherapy. Posted Date: June 7th, 2021 DOI: https://doi.org/10.21203/rs.3.rs-447123/v1 Page 1/23 License: This work is licensed under a Creative Commons Attribution 4.0 International License. Read Full License Page 2/23 Abstract Purpose To evaluate the impact of routine multidisciplinary allied health prehabilitation care in haematologic cancer patients receiving high-dose chemotherapy with autologous stem cell transplant (AuSCT). Methods In a tertiary cancer centre, 12-months of prospectively collected data was retrospectively analysed. Patients were referred to the service for individualised exercise prescription, nutrition intervention and, if indicated through screening, psychological intervention. Impact and operational success were investigated based on the RE-AIM framework: patient uptake of the service and sample representativeness (Reach); Effectiveness in terms of changes in outcomes from initial to pre-transplant assessment; Adoption of the service by key stakeholders; delity of the prescribed exercise program (Implementation); and the extent to which the service had become part of routine standard care (Maintenance).
    [Show full text]
  • Winning Over Cancer
    WINNING OVER CANCER AnnualAnnual Report Report2017 2017 1 CONTENTS During the last year, I have been overwhelmed by the outpouring of love and support that followed the news that my cancer had returned. Of course, it has been a personal challenge but OVERVIEW OUR COMMNUNITIES I feel privileged to be able to give hope to others Message from Olivia ............................................ 3 Equipment, facilities and services .............. 32 who are going through cancer. It’s a challenging and amazing journey that I have been through Chairman’s report ................................................ 4 T marks the spot .................................................34 before and I am winning over again! Year at a glance .................................................... 5 The synergy of circles ........................................36 I am grateful for and incredibly proud of the important work being done at the Olivia Directors’ report .................................................... 6 Clinician scientist fellowships ....................... 37 Newton-John Cancer Institute. It is hugely Collaborations and partnerships ................38 reassuring to know that scientists, doctors, OUR HIGHLIGHTS Students: the next generation .................... 40 volunteers and other healthcare practitioners are working around the clock to win over cancer Flicking the switch on Donors and supporters .....................................41 Message from and that they are helping so many people who colon cancer’s own killer ................................... 7 Amazing gift leaves a lasting come to the Centre for support. Reducing the costs of legacy for cancer research .............................43 our founding The ONJCRI holds a special place in my lung cancer misdiagnosis ................................. 8 heart in this regard. Medical research and Suppressing cancer cell corruption .............. 9 scientific endeavour run through my veins - OUR ORGANISATION champion, and although I chose a musical path, I am Rising to the challenge of lung cancer ...
    [Show full text]
  • Tumour Mutation Status and Sites of Metastasis in Patients with Cutaneous Melanoma
    FULL PAPER British Journal of Cancer (2017) 117, 1026–1035 | doi: 10.1038/bjc.2017.254 Keywords: cutaneous melanoma; melanoma; BRAF mutation; mutation status; metastasis; sentinel lymph node biopsy Tumour mutation status and sites of metastasis in patients with cutaneous melanoma Nikki R Adler*,1,2, Rory Wolfe2, John W Kelly1, Andrew Haydon1,3, Grant A McArthur4,5, Catriona A McLean1,6 and Victoria J Mar1,2,7 1Victorian Melanoma Service, Alfred Hospital, Melbourne, Victoria 3004, Australia; 2School of Public Health and Preventive Medicine, Monash University, Melbourne, Victoria 3004, Australia; 3Department of Medical Oncology, Alfred Hospital, Melbourne, Victoria 3004, Australia; 4Divisions of Research and Cancer Medicine, Peter MacCallum Cancer Centre, Melbourne, Victoria 3000, Australia; 5Sir Peter MacCallum Department of Oncology, University of Melbourne, Victoria 3000, Australia; 6Department of Anatomical Pathology, Alfred Hospital, Melbourne, Victoria 3004, Australia and 7Skin and Cancer Foundation, Carlton, Victoria 3053, Australia Background: Cutaneous melanoma can metastasise haematogenously and/or lymphogenously to form satellite/in-transit, lymph node or distant metastasis. This study aimed to determine if BRAF and NRAS mutant and wild-type tumours differ in their site of first tumour metastasis and anatomical metastatic pathway. Methods: Prospective cohort of patients with a histologically confirmed primary cutaneous melanoma at three tertiary referral centres in Melbourne, Australia from 2010 to 2015. Multinomial regression determined clinical, histological and mutational factors associated with the site of first metastasis and metastatic pathway. Results: Of 1048 patients, 306 (29%) developed metastasis over a median 4.7 year follow-up period. 73 (24%), 192 (63%) and 41 (13%) developed distant, regional lymph node and satellite/in-transit metastasis as the first site of metastasis, respectively.
    [Show full text]
  • Peter Mac Research Report 2007
    PETER MACCALLUM CANCER CENTRE PETER MACCALLUM RESEARCH REPORT JANUARY–DECEMBER 2007 JANUARY–DECEMBER www.petermac-research.org PETER MACALLUM CANCER CENTRE RESEARCH REPORT JANUARY–DECEMBER 2007 WWW.PETERMAC-RESEARCH.ORG CONTENTS Director’s REPORT 2 CHIEF EXECUTIVE Officer’s OVERVIEW 4 ORGANISATIONAL STRUCTURE 6 RESEARCH DIVISION PROGRAMS TRANSLATIONAL RESEARCH ETHICAL CONDUCT OF Cancer Immunology Program 8 PROGRAM 66 RESEARCH 121 Translational Research 68 Cancer Cell Death 10 COMMERCIALISATION 124 Cellular Immunity 13 Molecular Imaging 70 CORE TECHNOLOGIES 128 Gene Regulation 16 Centre for Blood Cell Therapies 72 Tissue Bank 130 Immune Signalling 18 Haematology Immunology Translational Research 75 Microscopy 131 Immunotherapy 20 Microarray 132 CLINICAL AND ASSOCIATED Cancer Genomics Program 22 RESEARCH 78 Flow Cytometry 133 VBCRC Cancer Genetics 24 Advanced Cancer Imaging 80 Media and Laboratory Services 134 Cancer Genetics and Genomics 27 Familial Cancer Centre 82 Bioinformatics 135 Surgical Oncology 30 Molecular Pathology 84 Sarcoma Genomics and Genetics 32 EDUCATION AND LEARNING 136 OnTrac@PeterMac 86 kConFab 34 PUBLICATIONS AND PATENTS 146 Nursing and Supportive Care Research 88 kConFab Follow-up Project 36 Infectious Diseases 91 Growth Control and Pharmacy 92 Differentiation Program 38 Psycho-oncology Research Unit 93 Protein Chemistry 40 Growth Control 42 CLINICAL TRIALS AND Molecular Oncology 44 MULTIDISCIPLINARY CARE 94 Haematology 96 Cancer Cell Biology Program 46 Breast 99 Cancer Biology 48 Head and Neck 102 Differentiation
    [Show full text]
  • Burns Chronicle 1938
    Robert BurnsLimited World Federation Limited www.rbwf.org.uk 1938 The digital conversion of this Burns Chronicle was sponsored by Frank Shaw The digital conversion service was provided by DDSR Document Scanning by permission of the Robert Burns World Federation Limited to whom all Copyright title belongs. www.DDSR.com BURNS CHRONICLE AND CLUB DIRECTORY INSTITUTED 1 8 9 1 PUBLISHED ANNUALLY SECOND SERIES : VOLUME XIII THE BURNS FEDERATION KILMARNOCK I 9 3 8 Price Three shillings "BURNS CHRONICLE" ADVERTISER A "WAUGH " CHIEFTAIN To ensure a successful BURNS DINNBR, or any dinner, you cannot do better than get your HAGGIS supplies from GEORGE WAUGH MAKER OF THE BEST SCOTCH HAGGIS since 1840 DELICIOUS AND. DISTINCTIVE The ingredients used are . the finest obtainable and very rich in VITAMINS, rendering it a very valuable food. A GLORIOUS DISH For delivery in the British Isles, any quantity supplied from l lb. to CHIEFTAIN size. For Export in skins within hermetically sealed Tins-postage extra. 1 lb. Tin 2/- 2 " " 3/6 3 " " 6/· GEORGE WAUGH 110 NICOLSON ST., EDINBURGH, 8 Kitchelll: TeJesmuns: Haggiston, Broughton Rd. " Haggis,"A Edinburgh Phone 25778 Pbone42849 "BURNS CHRONICLE" ADVERTISE]{ NATIONAL BURNS MEMORIAL COTTAGE HOMES, MAUCHLINE, AYRSHIRE. In Memory of the Poet Burns for Deserving Old People. "That greatest of benevolent Institutions established . In honour of Robert Burns." -6/aagow Herald. There are now eighteen modern . comfortable houses for the benefit of deserving old folks. Two further cottages are in course of erection. The site is an ideal one in the heart of the Burns Country. The Cottagers, after careful selection, get the houses free of rent and taxes and an annual allowance.
    [Show full text]
  • Edinburgh Friends 2011
    THE UNIVERSITYof EDINBURGH CAMPAIGN Edinburgh FriendsDECEMBER 2011 Connecting the dots How the University is helping to build the future of science and engineering INSIDE Edinburgh’s hidden gem: St Cecilia’s Hall How bursaries make a difference The University of Edinburgh Campaign supporters YOUR OPINION MATTERS contents We would love to hear what you Cover feature: How the think of the magazine. University’s investment in Please get in touch science and engineering is with Brian Campbell to helping to prepare us for the share your views challenges of tomorrow e: brian1. campbell@ page 18 ed.ac.uk 04 : 2011 HIGHLIGHTS 06 18 A round-up of some of this year’s Sign up for news and developments our monthly e-newsletter 06 : OUR SUPPORTERS to receive At a glance – where our regular supporters come from updates 10 26 on the 08 : WHY I GIVE University of Morag McIntyre explains why she and her husband 32 : BURSARIES Edinburgh funded a living memorial to their son Craig How an access bursary made a difference Campaign. to Colin Maclachlan Subscribe 10 : MEDICINE online at A look at some of the University’s latest projects 34 : LEGACIES www. in medical research Why David McCorquodale has pledged a legacy edinburgh 16 : OLD COLLEGE to the University campaign. The Old College quadrangle has been unveiled, ed.ac.uk 36 : CAMPAIGN SUPPORTERS revealing a beautiful addition to the building Recognition of the generous support from our friends and alumni 18 : COVER FEATURE How the University is investing in the future of science and engineering If you require this document in an alternative 26 : SPECIAL COLLECTIONS format, e.g.
    [Show full text]